Jazz Pharmaceuticals Aktie
WKN DE: A1JS1K / ISIN: IE00B4Q5ZN47
10.07.2025 14:13:55
|
Jazz Pharmaceuticals Picks Renee Gala As CEO
(RTTNews) - Jazz Pharmaceuticals plc (JAZZ), Thursday announced the decision to appoint Chief Operating Officer Renee Gala as the company's President and Chief Executive Officer, effective August 11, 2025.
The decision comes as CEO Bruce Cozadd informed the board in 2024 of his intent to retire from the position upon the selection of his successor.
Prior to Jazz, Gala served as senior vice president and CFO of Theravance Biopharma, Inc.
In the pre-market hours, Jazz's stock is trading at $111.50, down 0.09 percent on the Nasdaq.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Jazz Pharmaceuticals PLCmehr Nachrichten
04.08.25 |
Ausblick: Jazz Pharmaceuticals legt Quartalsergebnis vor (finanzen.net) | |
05.05.25 |
Ausblick: Jazz Pharmaceuticals legt die Bilanz zum abgelaufenen Quartal vor (finanzen.net) |
Analysen zu Jazz Pharmaceuticals PLCmehr Analysen
Aktien in diesem Artikel
Jazz Pharmaceuticals PLC | 109,90 | 12,03% |
|